• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Qlucore

0.30 SEK+13.16 %10/7 17:29
Less than 1K followers

QCORE

First North Stockholm

IT Services

Technology

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+13.16 %
-25.31 %
-26.41 %
-38.82 %
-39.56 %
-10.21 %
-93.49 %
-
-98.92 %

Qlucore develops AI-based software for use in the healthcare sector. The company's precision medicine solutions transform genetic data into decision-making data to create the right treatment for patients. The company's first diagnostic test – for blood cancer in children – has been approved and CE-marked. The company also has tests for lung cancer under development, and is developing the Qlucore Omics Explorer analysis software.

Read more
Market cap
12.91M SEK
Turnover
29.77K SEK
Revenue
6.74M
EBIT %
-539.84 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
9/9
2026

Interim report Q1'27

9/9
2026

General meeting '26

26/11
2026

Interim report Q2'27

Regulatory press release2026-06-26 18:30

Qlucore publicerar årsredovisning för 2025/2026

Qlucore
Press release2026-06-23 19:20

Qlucore erhåller EU utbetalning om cirka 0,5 MEUR

Qlucore
Press release2026-06-23 19:20

Qlucore Receives EUR 0.5 Million EU Payment

Qlucore

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2026-06-17 20:30

Qlucore erhåller godkännande för EU utbetalning om cirka 0,5 MEUR

Qlucore
Press release2026-06-17 20:30

Qlucore Receives Approval for EUR 0.5 Million EU Payment

Qlucore
Regulatory press release2026-05-28 08:30

Bokslutskommuniké 1 maj 2025 - 30 april 2026

Qlucore
Regulatory press release2026-05-28 08:30

Year-end-report 1 May 2025 - 30 April 2026

Qlucore
Press release2026-04-20 14:00

Qlucore lanserar AI-baserat test för blåscancer

Qlucore
Press release2026-04-20 14:00

Qlucore Launches AI-based test for Bladder Cancer

Qlucore
Press release2026-04-13 10:30

Qlucore lanserar AI baserat test för akut myeloisk leukemi

Qlucore
Press release2026-04-13 10:30

Qlucore Launches AI-based test for Acute Myeloid Leukemia

Qlucore
Regulatory press release2026-02-26 08:30

Delårsrapport 1 maj 2025 - 31 januari 2026

Qlucore
Regulatory press release2026-02-26 08:30

Interim report 1 May 2025 - 31 January 2026

Qlucore
Press release2026-02-23 17:10

Inbjudan till presentation med frågestund av Qlucores delårsrapport för perioden 1 maj 2025 – 31 januari 2026

Qlucore
Press release2026-02-23 17:10

Invitation to presentation including Q&A session of Qlucore’s interim report for the period 1 May 2025 – 31 January 2026

Qlucore
Press release2025-12-18 14:00

Ny version av Qlucore Omics Explorer med förbättrat stöd för fördjupad analys av proteindata

Qlucore
Press release2025-12-18 14:00

New version of Qlucore Omics Explorer with enhanced support for in-depth proteomics analysis

Qlucore
Regulatory press release2025-11-27 08:30

Delårsrapport 1 maj - 31 oktober 2025

Qlucore
Regulatory press release2025-11-27 08:30

Interim report 1 May - 31 October 2025

Qlucore
Regulatory press release2025-11-27 08:20

Utrangering av immateriella tillgångar

Qlucore